Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Embryonal Tumor With Multilayered Rosettes
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
- Status
- RECRUITING
- Phase
- PHASE3
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Sagittarius Trial
- Status
- RECRUITING
- Phase
- PHASE3
Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
- Status
- RECRUITING
- Phase
- PHASE1
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Status
- RECRUITING
- Phase
- PHASE2
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
STARLITE for Unresectable High-Grade Gliomas
- Status
- RECRUITING
- Phase
- PHASE1